Dashboard
Manage Tickers

RLAY


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jmp-securities-reiterates-market-outperform-on-relay-therapeutics-maintains-21-price-target
JMP Securities Reiterates Market Outperfor...
09/17/2024 16:14:56

JMP Securities analyst Silvan Tuerkcan reiterates Relay Therapeutics (NASDAQ:RLAY) with a Market Outperform and maintains $2...

stifel-reiterates-buy-on-relay-therapeutics-maintains-28-price-target
Stifel Reiterates Buy on Relay Therapeutic...
09/16/2024 12:39:02

Stifel analyst Bradley Canino reiterates Relay Therapeutics (NASDAQ:RLAY) with a Buy and maintains $28 price target.

hc-wainwright--co-maintains-buy-on-relay-therapeutics-raises-price-target-to-19
HC Wainwright & Co. Maintains Buy on Relay...
09/16/2024 11:14:42

HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and raises the price targ...

why-relay-therapeutics-rlay-stock-is-down-17-today
Why Relay Therapeutics (RLAY) Stock Is Dow...
09/11/2024 16:22:45

Relay Therapeutics shares are trading lower by 17.8% during Wednesday's session. The company priced its $200 million offering.

this-novartis-analyst-is-no-longer-bullish-here-are-top-downgrades-for-wednesday
This Novartis Analyst Is No Longer Bullish...
09/11/2024 16:13:54

gamestop-reports-weak-sales-joins-petco-relay-therapeutics-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
GameStop Reports Weak Sales, Joins Petco, ...
09/11/2024 12:06:25

why-dave--busters-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket
Why Dave & Buster's Shares Are Trading Hig...
09/11/2024 09:16:27

reported-earlier-relay-therapeutics-prices-200m-public-offering-of-28571429-common-shares-at-7share
Reported Earlier, Relay Therapeutics Price...
09/11/2024 06:26:33

 The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expec...

relay-therapeutics-faces-downgrade-over-efficacy-concerns-in-competitive-pi3k-inhibitor-market
Relay Therapeutics Faces Downgrade Over Ef...
09/10/2024 18:50:27

Relay Therapeutics shares interim data for RLY-2608 from the ReDiscover study, showing a 57% clinical benefit rate. Oppenheimer...

b-of-a-securities-maintains-buy-on-relay-therapeutics-raises-price-target-to-24
B of A Securities Maintains Buy on Relay T...
09/10/2024 15:55:08

B of A Securities analyst Jason Gerberry maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and raises the price target f...

jp-morgan-maintains-overweight-on-relay-therapeutics-lowers-price-target-to-21
JP Morgan Maintains Overweight on Relay Th...
09/10/2024 14:58:00

JP Morgan analyst Eric Joseph maintains Relay Therapeutics (NASDAQ:RLAY) with a Overweight and lowers the price target from ...

barclays-maintains-overweight-on-relay-therapeutics-raises-price-target-to-17
Barclays Maintains Overweight on Relay The...
09/10/2024 14:37:08

Barclays analyst Peter Lawson maintains Relay Therapeutics (NASDAQ:RLAY) with a Overweight and raises the price target from ...

this-johnson-controls-international-analyst-turns-bullish-here-are-top-5-upgrades-for-tuesday
This Johnson Controls International Analys...
09/10/2024 14:03:37

goldman-sachs-reinstates-buy-on-relay-therapeutics-announces-20-price-target
Goldman Sachs Reinstates Buy on Relay Ther...
09/10/2024 13:16:19

Goldman Sachs analyst Salveen Richter reinstates Relay Therapeutics (NASDAQ:RLAY) with a Buy and announces $20 price target.

jefferies-upgrades-relay-therapeutics-to-buy-raises-price-target-to-16
Jefferies Upgrades Relay Therapeutics to B...
09/10/2024 12:28:45

Jefferies analyst Akash Tewari upgrades Relay Therapeutics (NASDAQ:RLAY) from Hold to Buy and raises the price target from $...

oppenheimer-downgrades-relay-therapeutics-to-perform
Oppenheimer Downgrades Relay Therapeutics ...
09/10/2024 10:48:41

Oppenheimer analyst Matthew Biegler downgrades Relay Therapeutics (NASDAQ:RLAY) from Outperform to Perform.

dow-jumps-over-1-following-last-weeks-selloff-investor-sentiment-improves-but-fear--greed-index-remains-in-fear-zone
Dow Jumps Over 1% Following Last Week's Se...
09/10/2024 06:12:41

relay-therapeutics-commences-public-offering-of-200m-of-shares-of-its-common-stock
Relay Therapeutics Commences Public Offeri...
09/09/2024 20:35:16

Relay Therapeutics also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%)...

crude-oil-gains-over-1-relay-therapeutics-shares-spike-higher
Crude Oil Gains Over 1%; Relay Therapeutic...
09/09/2024 18:16:34

nasdaq-surges-over-1-us-wholesale-inventories-rise-02-in-july
Nasdaq Surges Over 1%; US Wholesale Invent...
09/09/2024 16:04:18

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION